Institute for Health Metrics and Evaluation (IHME) 214d ago

Nearly 1 in 3 individuals were affected by headache disorders in 2023 — a total of 3 billion people around the world. More than one-fifth of the global headache burden was linked to pain medication overuse highlighting major opportunities for safer pain management and improved access to care, according to a new study from IHME and Norwegian University of Science and Technology (NTNU) published in The Lancet Neurology. Yvonne Xu, co-author and research scientist at IHME, discusses the key findings from this research. Read the press release: https://www.healthdata.org/news-events/newsroom/news-releases/headache-disorders-affect-3-billion-people-worldwide-nearly-one Read the study: https://www.healthdata.org/research-analysis/library/global-regional-and-national-burden-headache-disorders-1990-2023 An independent population health research organization based at the University of Washington School of Medicine, the Institute for Health Metrics and Evaluation (IHME) works with collaborators around the world to develop timely, relevant, and scientifically valid evidence that illuminates the state of health everywhere. https://www.healthdata.org/ Where to follow us: • https://www.linkedin.com/company/institute-for-health-metrics-and-evaluation • https://twitter.com/IHME_UW • https://www.facebook.com/IHMEUW